Toth Financial Advisory Corp Boosts AbbVie Holdings

The investment firm increased its stake in the pharmaceutical company by over 6% in the fourth quarter.

Apr. 4, 2026 at 11:54am

Toth Financial Advisory Corp, an investment management firm, grew its holdings in shares of AbbVie Inc. (NYSE:ABBV) by 6.9% during the fourth quarter of 2025. The firm now owns 51,282 shares of the pharmaceutical company's stock, valued at $11.7 million as of its most recent SEC filing.

Why it matters

AbbVie is a major player in the pharmaceutical industry, with a diverse portfolio of drugs across several therapeutic areas. The increase in Toth Financial's stake suggests the firm sees continued growth potential in AbbVie's business, which could signal broader confidence in the company's future performance.

The details

According to the 13F filing, Toth Financial Advisory Corp added 3,300 shares of AbbVie to its portfolio during the fourth quarter. This brings the firm's total holdings in the company to 51,282 shares, accounting for 1.3% of its overall investment portfolio. The shares were valued at $11.7 million as of the end of 2025.

  • Toth Financial Advisory Corp filed its 13F report for the fourth quarter of 2025 on April 4, 2026.
  • The firm increased its AbbVie holdings during the three-month period ending December 31, 2025.

The players

Toth Financial Advisory Corp

An investment management firm that oversees a portfolio of stocks, bonds, and other financial assets on behalf of its clients.

AbbVie Inc.

A global biopharmaceutical company that focuses on developing and commercializing therapies for complex and chronic medical conditions.

Got photos? Submit your photos here. ›

The takeaway

Toth Financial's increased stake in AbbVie suggests the firm sees long-term growth potential in the pharmaceutical company's business, which could signal broader confidence in the industry and the stock's future performance.